Needle Gone
Data On
Empower your health journey with CGM innovation
CGM that does not compromise your comfort
In Clinical Testing with MIT
In Clinical Testing with MIT
Product
Details
1
Needle-free, thus no skin piercing
2
No sensor replacements—cost-effective with CGM-level accuracy
3
No compromise on convenience, designed for seamless integration into daily life
To perfect this innovative device, we use Raman spectroscopy, which is based on the principle that different molecules have different vibrational energies of scattered light.
If you want to utilize this principle in your research, we can provide you with a chip with a surface enhancement to make it easier to get Raman signals.
-
“Deep Learning Assisted Surface-Enhanced Raman Spectroscopy (SERS) for Rapid and Direct Nucleic Acid Amplification and Detection: Toward Enhanced Molecular Diagnostics” ACS Nano, Vol 17(18), 18332-18345, Sep, 2023 (IF 17.1, 5yr IF 17.1)
“Label-free atherosclerosis diagnosis through a blood drop of apolipoprotein E knockout mouse model using surface-enhanced Raman spectroscopy validated by machine learning algorithm” Bioengineering & Translational Medicine, Vol 8(4), e10529, July, 2023 (IF 10.684)
“Diagnosis of Ischemic Renal Failure Using SurfDiagnosis of Ischemic Renal Failure Using Surface-Enhanced Raman Spectroscopy and a Machine Learning Algorithmace-Enhanced Raman Spectroscopy and a Machine Learning Algorithm“ Analytical Chemistry, Vol 94(50), 17477–17484, Dec, 2022, (IF 8.008, 5yr IF 7.528)
“Selective Detection of Nano-Sized Diagnostic Markers Using Au-ZnO Nanorod-Based Surface-Enhanced Raman Spectroscopy (SERS) in Ureteral Obstruction Models” International journal of nanomedicine, Volume 2020:15 P 8121—8130, Oct, 2020, (IF 6.400, 5yr IF 6.761)
The Team
Aram Hong
-
Aram founded Apollon in 2021. Previously, he led a healthtech startup, where he raised millions of dollars in investment to fund the development of the company’s at-home genetic analysis testing kits. He also worked for EY at Seoul and Sydney. Aram has a keen eye for the future of the healthtech space, and has long felt that invasive diagnostics have outlived their usefulness. His mission is to develop convenient and accessible diagnostic tools that do not compromise on clinical accuracy. Aram received his Bachelor of Economics and Political Science from Yonsei University, Seoul, Korea, and his Master of Public Policy from Georgetown University, Washington, D.C.
Miyeon Jue, Ph.D.
-
Dr. Jue is the Chief Technical Officer of Apollon. Her work focuses on expanding the use of Raman spectroscopy to identify various substances in the body that cannot be identified by conventional diagnostics. Previously, she undertook postdoctoral research at the Biomedical Engineering Research Center at Asan Medical Center. Dr. Jue also completed a postdoc at the Post-Silicon Semiconductor Institute of the Korea Institute of Science and Technology and earned her doctorate in Physics from Kyung Hee University in Seoul, Korea.
Youngkyu Kim, Ph.D.
-
Dr. Kim is drawn to the miniaturization of optical medical devices. His dissertation focused on the development of smartphone-based endomicroscopy devices and the quantification of image data for preclinical and clinical applications. As a visiting scientist at Massachusetts Institute of Technology, he is working on the development and human subject validation of Apollon’s Raman-based CGM. He earned his bachelor's and master's degrees in biomedical engineering from Korea University and his doctorate in medicine from Ulsan University College of Medicine in Seoul, Korea.
Jun Ki Kim, Ph.D.
-
Dr. Kim is currently an associate professor at the Department of Convergence Medicine, University of Ulsan College of Medicine, and Asan Medical Center. He has over fifteen years of experience in optical technology and biomedical engineering research, and he has published over eighty academic papers as a result. He began his research in optics while obtaining his Ph.D. in Information and Communication Engineering at the Gwangju Institute of Science and Technology, Korea. Dr. Kim then explored the medical applications of his research as a fellow at Harvard Medical School and the Wellman Center for Photomedicine, Massachusetts General Hospital, Boston.
Join Us
Our mission to create life-enhancing biomedical technology continues, and we look forward to developing innovative devices that will benefit patients with many different medical concerns.
To achieve our ambitious goals, we’ve brought together a proven team of world-class experts. Founded in 2021, we have been working with Massachusetts Institute of Technology to develop a non-invasive CGM. We have offices in the greater Boston area, Seoul, and Osong, the medical device cluster in Korea. We are actively looking for experts who share our vision for the future. If you would like to be a part of Apollon, don’t hesitate to get in touch!
